Therapeutic vaccines for chronic diseases: successes and technical challenges

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2815-22. doi: 10.1098/rstb.2011.0103.

Abstract

Chronic, non-communicable diseases are the major cause of death and disability worldwide and have replaced infectious diseases as the major burden of society in large parts of the world. Despite the complexity of chronic diseases, relatively few predisposing risk factors have been identified by the World Health Organization. Those include smoking, alcohol abuse, obesity, high cholesterol and high blood pressure as the cause of many of these chronic conditions. Here, we discuss several examples of vaccines that target these risk factors with the aim of preventing the associated diseases and some of the challenges they face.

Publication types

  • Review

MeSH terms

  • Angiotensin II / immunology
  • Animals
  • Antibodies / therapeutic use*
  • Antibody Formation
  • Antihypertensive Agents / immunology
  • Antihypertensive Agents / therapeutic use
  • Chronic Disease / therapy*
  • Diabetes Mellitus, Type 2 / immunology
  • Diabetes Mellitus, Type 2 / therapy*
  • Humans
  • Hypertension / immunology
  • Hypertension / therapy*
  • Interleukin-1beta / immunology
  • Mice
  • Nicotine / immunology
  • Risk Factors
  • Smoking / immunology
  • Smoking / therapy
  • Smoking Cessation / methods*
  • Vaccination
  • Vaccines / immunology
  • Vaccines / therapeutic use
  • Vaccines, Virus-Like Particle / immunology
  • Vaccines, Virus-Like Particle / therapeutic use*

Substances

  • Antibodies
  • Antihypertensive Agents
  • Interleukin-1beta
  • Vaccines
  • Vaccines, Virus-Like Particle
  • nicotine Qbeta vaccine
  • Angiotensin II
  • Nicotine